CVS Health (CVS) Tops Q3 EPS by 9c, Beats on Revenue; Offers FY22 EPS Guidance
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $87.60 -1.4%
EPS Growth %: +2.5%
Financial Fact:
Dividends declared per common share (in dollars per share): 0.43
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: +2.5%
Financial Fact:
Dividends declared per common share (in dollars per share): 0.43
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q3 EPS of $2.09, $0.09 better than the analyst estimate of $2.00. Revenue for the quarter came in at $81.16 billion versus the consensus estimate of $76.76 billion.
GUIDANCE:
CVS Health sees FY2022 EPS of $8.55-$8.65, versus the consensus of $8.55.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk
- DA Davidson Reiterates Buy Rating on Vulcan Materials Company (VMC)
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
